Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
54,686,033
-
Shares change
-
+2,821,791
-
Total reported value, excl. options
-
$2,865,566,092
-
Value change
-
+$201,344,784
-
Put/Call ratio
-
25.41%
-
Number of buys
-
89
-
Number of sells
-
-73
-
Price
-
$52.4
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2018
205 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2018.
NovoCure Ltd - Common Stock (NVCR) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54,686,033 shares
of 111,111,111 outstanding shares and own 49.22% of the company stock.
Largest 10 shareholders include FMR LLC (10,845,246 shares), Vanguard Group Inc (5,424,908 shares), BlackRock Inc. (4,749,934 shares), BAILLIE GIFFORD & CO (3,527,100 shares), Capital World Investors (2,265,311 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,055,136 shares), FARALLON CAPITAL MANAGEMENT LLC (1,350,000 shares), STATE STREET CORP (1,346,384 shares), TimesSquare Capital Management, LLC (1,182,525 shares), and MACQUARIE GROUP LTD (1,104,117 shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.